14 yrs 1 monthsStarted on:05 Jun 2004
₹ 1927.84 Cras on: 20 Jun 2018
Long Term Horizon
Capital Appreciation

Minimum Investment

  • ₹ 5000.00 for Lumpsum

Investment Objective

The scheme seeks to generate consistent returns by investing in equity / equity related or fixed income securities of pharma and other associated companies.

Exit Load

No entry load will be charged for Subscriptions/Switch Ins W.E.F August 01, 2009. Exit Load for all subscriptions W.E.F August 24, 2009 is 1% if redeemed/Switched out on or before completion of 1 year from the date of allotment

Scheme Documents

Similar Funds
Franklin Build India Fund
Return (CAGR) 16.91%
Crisil Ranking 3
Value Research
ICICI Prudential Banking And Financial Services Fund
Return (CAGR) 19.81%
Crisil Ranking NA
Value Research
Return (CAGR) 24.35%
Crisil Ranking NA
Value Research
DSP BlackRock India T.I.G.E.R. Fund
Return (CAGR) 16.93%
Crisil Ranking 3
Value Research
UTI-Banking Sector Fund
Return (CAGR) 17.29%
Crisil Ranking NA
Value Research
Return (CAGR) 15.75%
Crisil Ranking NA
Value Research NA
Baroda Pioneer Banking And Financial Services Fund - Plan A
Return (CAGR) 13.54%
Crisil Ranking NA
Value Research
HDFC Infrastructure Fund
Return (CAGR) 5.54%
Crisil Ranking 5
Value Research
Aditya Birla Sun Life Banking And Financial Services Fund
Return (CAGR) 25.83%
Crisil Ranking NA
Value Research


TenureReturns (CAGR)
1 Month6.58
3 Month7.76
1 YR13.80
2 YR5.75
3 YR3.52

SIP Returns

TenureReturns (CAGR)
1 YR16.05
2 YR6.95
3 YR3.71
5 YR8.64
10 YR17.29


Company Name% Assets
Abbott India Ltd.11.05
Sun Pharmaceutical Inds. Ltd.10.47
Divi's Laboratories Ltd.9.77
Cipla Ltd.9.26
Sanofi India Ltd.8.89
Aurobindo Pharma Ltd.8.08
Biocon Ltd.7.95
Dr. Reddy's Laboratories Ltd.6.94
Thyrocare Technologies Ltd.6.1
Torrent Pharmaceuticals Ltd.4.89

Top Sectoral Holdings

Sector Name% Assets


Portfolio turnover ratio59
Standard Deviation14.99%

Sailesh Raj Bhan

Mr. Bhan is an MBA (Finance) and CFA.
Mr. Sailesh Raj Bhan has about 19 years experience in equity research and fund management, with over 10 years at Reliance Nippon Life Asset Management Limited (formerly Reliance Capital Asset Management Limited). He manages diversified equity schemes like Reliance Equity Opportunities Fund (the largest Flexicap Scheme in India with assets of USD 800 million) since its inception in 2005 and Reliance Top200 Fund (a large cap diversified equity fund) since its inception in 2007. In addition, for over 9 years, he has been managing two specialized sector funds - Reliance Pharma Sector Fund (the largest pharma sector fund in India) and Reliance Media and Entertainment Fund.

Other Funds Managed by Sailesh Raj Bhan

© CRISIL Limited 2017. All Rights Reserved